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Abstract. This work presents a survivability prediction model for rec-
tal cancer patients developed through machine learning techniques. The
model was based on the most complete worldwide cancer dataset known,
the SEER dataset. After preprocessing, the training data consisted of
12,818 records of rectal cancer patients. Six features were extracted
from a feature selection process, finding the most relevant characteristics
which affect the survivability of rectal cancer. The model constructed
with six features was compared with another one with 18 features in-
dicated by a physician. The results show that the performance of the
six-feature model is close to that of the model using 18 features, which
indicates that the first may be a good compromise between usability and
performance.
1 Introduction
The most common cancer of the digestive system is colorectal cancer, also known
as bowel cancer, which develops in the cells lining the colon and rectum [18].
About 70 percent of the colorectal cancer cases occur in the colon and about
30 percent in the rectum [9]. Although colon and rectal cancers are considered
to be very similar pathologies, they have different associated genetic causes and
different progressions according to distinct molecular pathways [21]. The work
disclosed herein focuses solely on rectal cancer, the anatomic part where mate-
rial called feces or stool is stored until it is expelled of the body through the
anus. Machine learning (ML) methods have been widely applied in cancer re-
search, due to their competence in identifying relevant information from complex
datasets. An accurate survivability prediction helps physicians in effective and
precise decision-making. Although there are some tools which provide surviv-
ability predictions for rectal cancer, none of them apply ML techniques in order
to build evolving predictive models. Therefore, and following the previous work
developed for colon cancer patients[17], the aims of this work are the following:
i) to make an individualized prediction of the survivability of a rectal cancer
patient in each year of the five years following treatment; and ii) to determine
which features are the most important for survivability prediction of rectal can-
cer patients. The number of features can be crucial when available in a clinical
decision support tool, which is the end goal of the work. The number can de-
termine the use or not of a application, taking into account the time to obtain
an output (a prediction). The prediction model was developed using data from
the Surveillance, Epidemiology, and End Results (SEER) program [13], the most
complete cancer database in the world.
The paper is structured as follows. Section 2 describes related work in rectal
cancer survival prediction. Section 3 provides the steps and machine learning
methods used to develop the prediction model. The corresponding experimental
results are disclosed and discussed in Section 4. Finally, Section 5 presents the
conclusions drawn so far and future work considerations.
2 Related Work
Existing approaches to calculate rectal cancer patients survivability are regression-
based. Wang et al. [20] developed nomograms to make an individualized predic-
tion of the conditional survivability for rectal cancer patients. The estimate is
valid when calculated after a certain period of time (months) passed since di-
agnosis and treatment. The model was constructed based on data from 42,830
patients who were diagnosed between 1994-2003, from the SEER database. Con-
ditional survivability prediction is calculated from a Cox proportional hazards
model. The primary outcome variable was overall survivability conditional on
having survived up to 5 years from diagnosis. Covariates included in the model
were age, race, sex/gender and stage. The C-index for the model of this approach
was 0.75 and the model is available as a web-based calculator. Valentini et al.
[19] developed a tool to predict the probability that a rectal cancer patient will
be alive or will have local recurrence or distant metastasis after delivery of long-
course radiotherapy, with optional concomitant and/or adjuvant chemotherapy,
over a 5-year period after surgery. Based on Cox regression, multivariate nomo-
grams were developed through 2,795 individual patient data collected from five
European randomized trials1, between 1992 to 2003. Selected by training data,
the required information for the overall survivability calculator was gender, age
at the date of randomization, clinical tumor stage, radiotherapy dose, surgery
procedure, adjuvant chemotherapy (yes/no), pathological tumor and nodal stage.
The concomitant chemotherapy (yes/no) is used to calculate the local recurrence.
However, it must be inserted, even for overall survivability prediction, because
it is a field required for the tool. The nomogram for overall survivability had a
C-index of 0.70. Another SEER-based approach is the one developed by Bowles
et al. [1], also made available in the form of an internet-based individualized con-
ditional survivability calculator. This tool consists of four separate multivariate
Cox regression models, taking into account: no radiotherapy, preoperative radio-
therapy, postoperative radiotherapy and stage IV patients. These models were
1Trial name: European Organisation for Research and Treatment of Cancer,
Fdration Francophone de Cancrologie Digestive, Working Group of Surgical Oncol-
ogy/Working Group of Radiation Oncology/Working Group of Medical Oncology of
the Germany Cancer Society, Polish and Italian.
created to determine adjusted survival estimates (at year 1 through 10) and used
to calculate 5-year adjusted conditional survivability. They were constructed us-
ing registries of 22,610 patients with rectal adenocarcinoma, who were diagnosed
from January 1988 to December 2002. Models developed for patients who under-
went no radiotherapy, preoperative radiotherapy or postoperative radiotherapy,
covariates were the same. They included age, sex/gender, race, tumor grade,
surgery type and stage. In the model built for stage IV patients, i.e., for patients
with distant metastasis, the surgery type was treated as a binary variable in the
model (using any radiotherapy or primary tumor directed surgery as covariates).
The measures of performance for this tool are not available.
The approach developed herein distances itself from already existing works
by treating survival prediction as a classification problem and applying varied
machine learning methods to obtain a qualified model of individualized survival
prediction.
3 Development of the Prediction Model
The rectal cancer survival prediction model should have the capacity to accept
a number of inputs for selected prediction features and, for each of the 5 years
following treatment, produce an output stating whether the patient will survive
that year or not, along with a confidence value for the prediction. Survivability
prediction was approached as a binary classification problem, so that five classi-
fication models for each year were developed and were posteriorly combined, in
a programmatic manner. The development of these prediction models involved
the following phases by order of occurrence: preprocessing of SEER data, split
dataset, balancing data, feature selection, modeling, and evaluation. The soft-
ware chosen to develop the prediction model was RapidMiner, an open source
data mining software. It has a workflow-based interface that offers an intuitive
application programming interface (API).
3.1 Preprocessing, Split Dataset, and Balancing Data
The colorectal cancer data from SEER were collected from 1973 to 2012. It
contained 515,791 registries and 146 attributes, some of them only applicable to
a limited period within the time of data collection. In the Preprocessing phase, it
was defined that the period of interest would be from 2004 onwards, minimizing
the occurrence of missing data due to the applicability of the attributes. Pediatric
patients (age under to 18 years old) were removed. Patients who were alive at the
end of the data collection whose survival time had not yet reached five years (the
maximum period for which the model under development is supposed to predict
survival), and those who passed away of causes other than colon or rectal cancer
were sampled out from the training set as their inclusion was considered to be
unsuited to the problem at hand. Binary classes (survived and not survived)
were derived for the target labels 1-, 2-, 3-, 4- and 5-year survival. Finally, based
on existing attributes and at the request of a physician who collaborated in this
work, new attributes, such as the number of regional lymph negative nodes, the
ratio of positive nodes over the total examined nodes and also patient relapse,
were calculated. After the Preprocessing phase, the attributes were reduced to
61, including the new attributes and the target labels and the data was reduced
to 12,818 registries. During the Split Dataset phase, the data was separated
into five sub-datasets by target label, taking into account the corresponding
survivability year. Table 1 shows the class distribution in each sub-dataset.
Observing Table 1 is seen that the classes are not equally represented. Studies
[4, 11] show that the problem of using imbalanced datasets is important, from
both the algorithmic and performance perspectives. An overview of classification
algorithms for the resolution of this kind of problem [7] concluded that hybrid
sampling techniques, i.e., combining over-sampling of the minority class with
under-sampling of the majority class, can achieve better performances than just
oversampling or undersampling. As such, in the Balancing Data phase, hybrid
sampling, as described in [7], was applied in order to generate balanced sub-
datasets with 12,818 records each.
Table 1: Class distribution for each target label in the sub-datasets.
Target Labels
1 Year 2 Year 3 Year 4 Year 5 Year
Not Survived 4.03% 5.89% 7.17% 8.08% 8.70%
Survived 87.88% 82.27% 78.41% 75.68% 73.79%
3.2 Feature Selection
For the Feature Selection phase was used the Optimize Selection operator (im-
plementing a deterministic and optimized selection process with decision trees
and forward selection)[15] of RapidMiner. This phase was essential to discover
the most influential features on the survival of rectal cancer patients. The process
was applied to each sub-dataset for the target label and the common selected
features to all the sub-datasets were used to construct the prediction models.
Table 2 shows the selected features and their meaning. The 6 selected features
were compared with a set of 18 features indicated by a specialist physician on
colorectal cancer. In the subsequent modelling, it was assumed that the features
had an equal weight, but further experimentation with biased models is required.
3.3 Modeling and Evaluation
During the Modeling phase, the classification strategy adopted consisted in the
application of ensemble methods. In order to boost basic classifiers and improve
their performance, the classification schemes used were meta-classifiers. All the
classifiers combinations were explored, according to the algorithms and type of
attributes allowed. The tested meta-classifiers were the same used in the previous
Table 2: Attributes selected in the Feature Selection process.
Attribute Description
Age recode
with < 1 year old
Age groupings based on age at diagnosis (single-year
ages) of patients (< 1 year, 1-4 years, 5-9 years, ...,
85+ years)
CS Site-Specific Factor 1
The interpretation of the highest Carcinoembryonic
Antigen (CEA)2 test results
CS Site-Specific Factor 2 The clinical assessment of regional lymph nodes
Derived AJCC Stage Group The grouping of the TNM information combined
Primary Site
Identification of the site in which the primary tumor
originated
Regional Nodes Examined
The total number of regional lymph nodes that were
removed and examined by the pathologist
work about colon cancer survability prediction [17]: AdaBoost [6], Bagging [3],
Bayesian Boosting [15], Stacking [5], and Voting [10].
Since survivability prediction is being handled as a classification problem,
a group of basic classifiers were selected to be used in ensembles with the
above-described meta-classifiers. The group includes some of the most widely
used learners [15] available in RapidMiner, namely the k-NN (Lazy Modeling),
the Naive Bayes (Bayesian Modeling), the Decision Tree (Tree Induction), and
the Random Forest (Tree Induction). Fourteen classification schemes were con-
structed for the sets of 6 and 18 attributes and, for 1, 2, 3, 4, and 5 survival years.
The combinations of meta-classifiers with basic classifiers were as follows. The
Voting model used k-NN, Decision Tree and Random Forest as base learners.
The Stacking model used k-NN, Decision Tree, and Random Forest classifiers
as base learners, and a Naive Bayes classifier as a Stacking model learner. The
AdaBoost, Bagging, and Bayesian Boosting models were combining with each
basic classifier. In the evaluation process, 10-fold cross-validation [16] was used to
assess the prediction performance of the generated prediction models and avoid
overfitting. All classification schemes was evaluated and comparared using the
prediction accuracy and the area under the ROC curve (AUC). The accuracy is
the percentage of correct responses among the examined cases [2]. The AUC can
be interpreted as the percentage of randomly drawn data pairs of individuals
that have been accurately classified in the two populations, and it is commonly
used as a measure of quality for classification models [2].
4 Experimental Results and Discussion
A vast quantity of results was analyzed. From the results obtained, the top three
performing algorithms, for each evaluating method described in Section 3, are
present in Tables 3 and 4, for each of the 5 years. For an easier interpretation,
the average performances were calculated, allowing a better comparison between
algorithms and the selection of the best model. This is shown in Figure 1a and
Figure 1b for the top three performing algorithms.
Table 3: Survivability Percentage Accuracy.
Accuracy
1 Year 2 Year 3 Year 4 Year 5 Year
Ensemble Model 18 attributes 6 attributes 18 attributes 6 attributes 18 attributes 6 attributes 18 attributes 6 attributes 18 attributes 6 attributes
Stacking 98.32% 96.45% 98.00% 96.15% 97.72% 95.79% 96.97% 95.05% 96.88% 95.01%
Voting 97.37% 95.97% 97.16% 95.91% 97.20% 95.32% 96.79% 94.63% 96.62% 94.64%
Bayesian Boosting
with Decision Tree
97.16% 96.26% 97.08% 96.06% 96.75% 95.19% 96.22% 95.01% 96.42% 94.66%
Table 4: Survivability AUC.
AUC
1 Year 2 Year 3 Year 4 Year 5 Year
Ensemble Model 18 attributes 6 attributes 18 attributes 6 attributes 18 attributes 6 attributes 18 attributes 6 attributes 18 attributes 6 attributes
Stacking 0.988 0.976 0.989 0.981 0.987 0.979 0.984 0.977 0.986 0.977
Voting 0.985 0.975 0.983 0.976 0.983 0.971 0.979 0.969 0.979 0.969
Bagging with
Decision Tree
0.985 0.981 0.974 0.964 0.964 0.955 0.967 0.948 0.962 0.951
Among the 18-attribute models, the stacking algorithm stood out . Among
the 6-attribute models, the same has happened. The 18-attribute models had
an average accuracy of 97.58%, with values for years 1 to 5 of 98.32%, 98.00%,
97.72%, 96.97% and 96.88%. The average AUC was 0.987, and the remaining
values were 0.988, 0.989, 0.987, 0.984 and 0.986 for years 1 to 5. With an average
of 95.69% for accuracy and 0.978 for AUC, the 6-attribute stacking models had
prediction accuracies for years 1 to 5 of 96.45%, 96.15%, 95.79%, 95.05% and
95.01% (as seen in Table 3), and AUCs of 0.976, 0.981, 0.979, 0.977 and 0.977
(as seen in Table 4). Comparing the results of the 6-attribute stacking models
with those of the 18-attribute models, the performances values are close, being
slightly better for the 18-attribute models. The gap between accuracy measures
are 1.89% and 0.009 for AUC. It is possible to say that the differences are not sig-
nificant, taking account the contrast of feature numbers. The results show that
it is possible to build a model with less than half of the features indicated by
the expert physician. Regarding the attributes obtained in the feature selection
process, with the exception of the site-specific factors, they were all connected
with the features indicated by the specialist physician. The regression based ap-
proaches mentioned in Section 2 utilized the C-index to evaluate the models.
This measure and AUC are considered numerically identical [8]. Since both cor-
respond to the probability of giving a correct response in a binary prediction
problem. As such, the present work represents an improvement and was able to
achieve better results. In addition, comparing this approach with the previous
work developed for colon cancer[17], results were similar. The third performing
algorithm was not the same. However, the best performance scheme also was
Stacking. In the colon cancer prediction model, the performance values were
slightly better, but not more than 1.13% for accuracy and 0.011 for AUC. The
most surprising result of the both approaches are the selected features, which
were the same.
(a) Average survivability percentage
accuracy.
(b) Average survivability AUC.
Fig. 1: Comparison of the 18-attribute models with the 6-attribute models.
5 Conclusions and Future Work
This work involved the application of different meta-classification schemes to
construct survivability prediction models for rectal cancer patients. The best
performing scheme presented uses a Stacking classification scheme, combining
k-NN, Decision Tree, and Random Forest classifiers as base learners and a Naive
Bayes classifier as a stacking model learner. The relevant number of features
for rectal cancer survivability prediction was found to be 6, the same selected
for colon cancer. The set includes: age, CS site-specific factor 1, CS site-specific
factor 2, derived AJCC stage group, primary site, and regional nodes examined.
Overall, the developed model was able to present a good performance with fewer
features than the existing approaches. As future work we intend to construct a
mobile application to make both models (colon and rectal cancer prediction
models) available to the health care community and to integrate it in settings of
ambient assisted living and group decision making [14, 12]. In order to have the
tool always updated and adapted to new patients, an on-line learning scheme
is being prepared. This functionality will allow to dynamically feed new cases
to the prediction system and make it change in order to provide better survival
predictions. Future work also includes the development of conditional survivabil-
ity models, enabling the user to get a prediction knowing that the patient has
already survived a number of years after diagnosis and treatment. Additionally,
we intend to conduct experiments to assess how well the tool fulfils the needs of
health care professionals and identify aspects to improve.
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